PharmaCyte Biotech Inc (PMCB)
2.16
-0.02
(-0.76%)
USD |
NASDAQ |
May 10, 16:00
2.16
0.00 (0.00%)
After-Hours: 19:36
PharmaCyte Biotech Free Cash Flow (Quarterly): -0.1771M for Jan. 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | -0.1771M |
| October 31, 2023 | -1.984M |
| July 31, 2023 | 0.343M |
| April 30, 2023 | -0.2884M |
| January 31, 2023 | -0.5417M |
| October 31, 2022 | -1.879M |
| July 31, 2022 | -1.084M |
| April 30, 2022 | -1.192M |
| January 31, 2022 | -0.2986M |
| October 31, 2021 | -1.386M |
| July 31, 2021 | -1.241M |
| April 30, 2021 | -0.9403M |
| January 31, 2021 | -0.5891M |
| October 31, 2020 | -1.250M |
| July 31, 2020 | -0.551M |
| April 30, 2020 | -0.6394M |
| January 31, 2020 | -0.3522M |
| October 31, 2019 | -0.5836M |
| July 31, 2019 | -0.7631M |
| April 30, 2019 | -0.6614M |
| January 31, 2019 | -0.6765M |
| October 31, 2018 | -0.9178M |
| July 31, 2018 | -0.6222M |
| April 30, 2018 | -1.375M |
| January 31, 2018 | -1.173M |
| Date | Value |
|---|---|
| October 31, 2017 | -1.596M |
| July 31, 2017 | -0.9356M |
| April 30, 2017 | -0.8009M |
| January 31, 2017 | -0.9253M |
| October 31, 2016 | -0.7063M |
| July 31, 2016 | -0.9069M |
| April 30, 2016 | -1.219M |
| January 31, 2016 | -1.011M |
| October 31, 2015 | -1.053M |
| July 31, 2015 | -1.064M |
| April 30, 2015 | -1.092M |
| January 31, 2015 | -1.065M |
| October 31, 2014 | -1.617M |
| July 31, 2014 | -0.7868M |
| April 30, 2014 | -1.938M |
| January 31, 2014 | -0.2497M |
| October 31, 2013 | -2.707M |
| July 31, 2013 | -0.1597M |
| April 30, 2013 | -0.143M |
| January 31, 2013 | -0.0776M |
| October 31, 2012 | -0.0845M |
| July 31, 2012 | -0.0854M |
| April 30, 2012 | -0.052M |
| January 31, 2012 | -0.0361M |
| October 31, 2011 | -0.0516M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-1.984M
Minimum
Oct 2023
0.343M
Maximum
Jul 2023
-0.8105M
Average
-0.6394M
Median
Apr 2020
Free Cash Flow (Quarterly) Benchmarks
| CEL-SCI Corp | -4.953M |
| AIM ImmunoTech Inc | -9.956M |
| IGC Pharma Inc | -1.674M |
| NovaBay Pharmaceuticals Inc | -0.316M |
| Protalix BioTherapeutics Inc | 3.345M |